Healthcare providers typically treat hemophilia B with factor replacement therapy. In factor replacement therapy, providers inject concentrated factor 9 into people’s bloodstreams. The concentrated factor 9 takes the place of the missing factor and helps prevent excessive bleeding or control bleeding when it happens. Usually, people with mild or moderate hemophilia B only need replacement therapy when they need surgery. People who have severe hemophilia B may need regular factor replacement therapy.